FDA Accepts Submission to Add PH-ILD to Yutrepia ™ Label

MORRISVILLE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Company’s amendment to the tentatively approved...

https://www.drugs.com/nda/yutrepia_230925.html

Source: Drugs.com - New Drug Applications - September 25, 2023 Category: Drugs & Pharmacology Source Type: news

More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | New Drug Applications